Health
New brain therapy allows paralyzed patients to walk again: 'I feel my legs'
New research suggests that paralyzed patients could regain some degree of movement — perhaps even walk again.
In a study led by EPFL (Swiss Federal Technology Institute of Lausanne) and Lausanne University Hospital in Switzerland, two people with spinal cord injuries received deep brain stimulation (DBS) therapy.
The therapy was applied to an “unexpected” part of the brain called the lateral hypothalamus, which has previously been associated with functions like eating and arousing from sleep.
MAN PARALYZED IN DIVING MISHAP HAS MEDICAL MIRACLE A YEAR AFTER AI-POWERED BRAIN IMPLANT
After the stimulation, the patients were able to walk without assistance and even climb stairs, according to a press release from Lausanne University Hospital.
The findings were published in the journal Nature Medicine.
One of the participants in the study was 54-year-old Wolfgang Jäger from Kappel, Austria, who experienced a spinal cord injury in 2006 that left him in a wheelchair.
The clinical trial participant, Wolfgang Jäger, gets out of his wheelchair and climbs up and down the steps using the deep brain stimulation of the lateral hypothalamus. (.NeuroRestore / EPFL)
After having electrodes implanted in the targeted area of his brain and receiving deep brain stimulation, he regained some lower-body mobility.
“Last year on vacation, it was no problem to walk a couple of steps down and back to the sea using the stimulation,” Jäger said in the release.
“I can also reach things in my cupboards in the kitchen.”
SPINAL CORD TREATMENT RESTORES FUNCTION FOR PARALYZED PATIENTS IN STUDY: ‘NEW HOPE’
Study author Jocelyne Bloch, neurosurgeon and professor at the Lausanne University Hospital, UNIL and EPFL, shared the immediate effects of the therapy.
“Once the electrode was in place and we performed the stimulation, the first patient immediately said, ‘I feel my legs,’” she said in the release.
The therapy was applied to an “unexpected” part of the brain called the lateral hypothalamus, which has previously been associated with functions like eating and arousing from sleep. (.NeuroRestore / EPFL)
“When we increased the stimulation, she said, ‘I feel the urge to walk!’ This real-time feedback confirmed we had targeted the correct region, even if this region had never been associated with the control of the legs in humans.”
“At this moment, I knew we were witnessing an important discovery of the anatomical organization of brain functions,” added Bloch.
“When we increased the stimulation, she said, ‘I feel the urge to walk!’”
The participants also reported “long-term improvement” in mobility even when the stimulation wasn’t actively being applied.
“This research highlights the unexpected role of the lateral hypothalamus, a brain region not previously associated with locomotion in humans,” lead researcher Dr. Grégoire Courtine, professor of neuroscience at EPFL and Lausanne University Hospital and co-director of the .NeuroRestore center, told Fox News Digital.
RESEARCHERS FIND SOURCES OF FOUR BRAIN DISORDERS, WHICH COULD LEAD TO NEW TREATMENTS
“Our findings show that this approach not only enhances motor abilities during stimulation, but also induces a reorganization of nerve fibers, leading to lasting improvements even in the absence of stimulation.”
DBS has traditionally been used to control tremors in people with movement disorders like Parkinson’s disease, the researchers noted.
A visual representation of deep brain stimulation of the lateral hypothalamus is shown. (.NeuroRestore / EPFL)
The concept of applying it to the lateral hypothalamus is unchartered territory.
Looking ahead, the researchers hope to combine DBS with spinal implants to enable further recovery from paralysis.
“Integrating our two approaches — brain and spinal stimulation — will offer a more comprehensive recovery strategy for patients with spinal cord injuries,” added Courtine.
‘Pushing science forward’
Dr. Ann Murray, director of the Comprehensive Movement Disorder Clinic at WVU Rockefeller Neuroscience Institute in West Virginia, said the study’s results are “surprising and exciting.”
“The targeted location of the brain they were stimulating, the hypothalamus, has not historically been known to be involved in the mechanism of gait,” Murray, who was not involved in the study, told Fox News Digital.
ALZHEIMER’S PATIENT, 90, SAYS SKIING AND OTHER ACTIVITIES KEEP HIM MENTALLY SHARP
“As we continue to better understand the brain networks, it will continue to enable us to modulate areas that aren’t working correctly,” she went on.
“The brain communicates via electrical signaling, and technologies like deep brain stimulation therapy help us interface with the brain circuitry to improve and/or restore more normal connectivity.”
“The brain communicates via electrical signaling, and technologies like deep brain stimulation therapy help us interface with the brain circuitry to improve and/or restore more normal connectivity,” a neurologist said. (.NeuroRestore / EPFL)
The potential for advancements in these types of technologies is “truly endless,” Murray said.
“I have the utmost hope that technologies like deep brain stimulation and other neuromodulation therapies will continue to advance the science in restoration of brain health for patients suffering neurologic injury.”
Potential limitations
The researchers acknowledged that there are some limitations of the research.
“This is precision medicine at its finest.”
“This therapy is only beneficial for patients with incomplete injuries, where functional neural circuits remain but are not fully utilized,” Courtine told Fox News Digital.
“For complete spinal cord injuries, only localized epidural electrical stimulation or a brain-spine interface bridge may assist in restoring functional movements.”
After having electrodes implanted in the targeted area of his brain and receiving deep brain stimulation, a clinical trial participant was able to climb the stairs. (.NeuroRestore / EPFL)
He also pointed out that this study is an “early-stage safety and feasibility trial,” conducted without a control group.
“For this therapy to become widely accessible, larger pivotal studies will need to be completed and thoroughly evaluated [before approval],” Courtine said.
“This process may take several years before the therapy becomes available to patients.”
Murray also emphasized that caution must be taken with this type of stimulation.
“Anytime we are investigating brain therapies, a tremendous degree of safety and precision has to be applied,” she cautioned.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“The brain is the most precise, complicated organ in the body, which requires any treatment or innovation to appreciate not just the intended effects, but the potential unintended effects of interfering with certain networks.”
Every step of the process must be carefully executed by a comprehensive team, Murray said.
“Anytime we are investigating brain therapies, a tremendous degree of safety and precision has to be applied,” a neurologist cautioned. (iStock)
“This is precision medicine at its finest — any misstep in any one of those stages can result in suboptimal outcomes.”
The goal, she said, is to standardize this process so that more patients have access to this “life-changing therapy.”
For more Health articles, visit www.foxnews.com/health
Added Murray, “This should give hope to millions of patients across the world suffering from neurologic conditions, as this is pushing the technology, pushing the science forward, to expand treatment to people that have never had any other options.”
Health
Melissa Joan Hart, 49, Opens up About Weight Loss in Perimenopause
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Alzheimer’s prevention breakthrough found in decades-old seizure drug
NEWYou can now listen to Fox News articles!
A drug that has long been used to treat seizures has shown promise as a potential means of Alzheimer’s prevention, a new study suggests.
The anti-seizure medication, levetiracetam, was first approved by the FDA in November 1999 under the brand name Keppra as a therapy for partial-onset seizures in adults. The approval has since expanded to include children and other types of seizures.
Northwestern University researchers recently found that levetiracetam prevented the formation of toxic amyloid beta peptides, which are small protein fragments in the brain that are commonly seen in Alzheimer’s patients.
The medication was found to prevent the formation of amyloid-beta 42 in both animal models and cultured human neurons, according to the study findings, which were published in Science Translational Medicine.
The effect was also seen in post-mortem human brain tissue obtained from individuals with Down syndrome, who are at high risk for Alzheimer’s disease.
The medication was found to prevent the formation of amyloid-beta 42 in both animal models and cultured human neurons. (iStock)
“While many of the Alzheimer’s drugs currently on the market, such as lecanemab and donanemab, are approved to clear existing amyloid plaques, we’ve identified this mechanism that prevents the production of the amyloid‑beta 42 peptides and amyloid plaques,” said corresponding author Jeffrey Savas, associate professor of behavioral neurology at Northwestern University Feinberg School of Medicine, in a press release.
“Our new results uncovered new biology while also opening doors for new drug targets.”
HIDDEN BRAIN CONDITION MAY QUADRUPLE DEMENTIA RISK IN OLDER ADULTS, STUDY SUGGESTS
The brain is better able to avoid the pathway that produces toxic amyloid‑beta 42 proteins in younger years, but the aging process gradually weakens that ability, Savas noted.
“This is not a statement of disease; this is just a part of aging. But in brains developing Alzheimer’s, too many neurons go astray, and that’s when you get amyloid-beta 42 production,” he said.
The effect was also seen in post-mortem human brain tissue obtained from individuals with Down syndrome, who are at high risk for Alzheimer’s disease. (iStock)
That then leads to tau (“tangles”) — abnormal clumps of protein inside brain neurons — which can kill brain cells, trigger neuroinflammation and lead to dementia.
In order for levetiracetam to function as an Alzheimer’s blocker, high-risk patients would have to start taking it “very, very early,” Savas said — up to 20 years before elevated amyloid-beta 42 levels would be detected.
CLICK HERE FOR MORE HEALTH STORIES
“You couldn’t take this when you already have dementia, because the brain has already undergone a number of irreversible changes and a lot of cell death,” the researcher noted.
The researchers also did a deep dive into previous human clinical data to determine whether Alzheimer’s patients who were taking the anti-seizure drug had slower cognitive decline. They reported that the patients in that category had a “significant delay” in the span from cognitive decline to death compared to those not taking the drug.
“This analysis supports the positive effect of levetiracetam to slow the progression of Alzheimer’s pathology,” the researcher said. (iStock)
“Although the magnitude of change was small (on the scale of a few years), this analysis supports the positive effect of levetiracetam to slow the progression of Alzheimer’s pathology,” Savas said.
Looking ahead, the research team aims to find people who have genetic forms of Alzheimer’s to participate in testing, Savas said.
Limitations and caveats
The study had several limitations, including that it relied on animal models and cultured cells, with no human trials conducted.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Because the study was observational in nature, it can’t prove that the medication caused the prevention of the toxic brain proteins, the researchers acknowledged.
Savas noted that levetiracetam “is not perfect,” cautioning that it breaks down in the body very quickly.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The team is currently working to create a “better version” that would last longer in the body and “better target the mechanism that prevents the production of the plaques.”
“You couldn’t take this when you already have dementia, because the brain has already undergone a number of irreversible changes and a lot of cell death.”
The medication’s common documented side effects include drowsiness, weakness, dizziness, irritability, headache, loss of appetite and nasal congestion.
It has also been linked to potential mood and behavior changes, including anxiety, depression, agitation and aggression, according to the prescribing information. In rare cases, it could lead to severe allergic reactions, skin reactions, blood disorders and suicidal ideation.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Funding for the study was provided by the National Institutes of Health and the Cure Alzheimer’s Fund.
Fox News Digital reached out to the drug manufacturer and the researchers for comment.
Health
Seniors over 80 who eat specific diet may be less likely to reach 100 years old
NEWYou can now listen to Fox News articles!
Older adults who avoid meat in their golden years may be less likely to reach age 100 than their meat-eating counterparts, new research suggests.
Researchers tracked more than 5,000 adults aged 80 or older who were enrolled in the Chinese Longitudinal Healthy Longevity Survey.
Between 1998 and 2018, data showed that those who did not eat meat were less likely to reach their 100th birthday than those who consumed animal products regularly.
The findings seem to contradict previous studies that have linked vegetarianism and plant-based diets to lower risks of heart disease, stroke, diabetes and obesity.
Most evidence supporting the benefits of plant-based diets comes from studies tracking younger populations, the researchers noted.
The findings contrast with previous research praising plant-based diets for their positive influence on heart health. (iStock)
The study, published in The American Journal of Clinical Nutrition, points to losses in muscle mass and bone density with age, shifts that can increase the risk of malnutrition and frailty in the “oldest old.”
As people enter their 80s and 90s, the nutritional priority often shifts from preventing long-term chronic diseases to maintaining day-to-day physical function, experts say.
HOW MUCH RED MEAT IS TOO MUCH? EXPERTS WEIGH IN ON FOOD PYRAMID UPDATES
“The headline ‘vegetarians over 80 less likely to reach 100’ sounds surprising, because it contrasts with decades of data linking plant‑forward diets to lower chronic disease risk earlier in life,” Erin Palinski-Wade, a New Jersey-based registered dietitian, told Fox News Digital.
“However, once you see that this research is limited to adults over the age of 80 who are also underweight — and that this link disappears with the consumption of eggs, dairy and fish — the results are less surprising.”
While diets earlier in life tend to emphasize avoiding long-term disease, older age necessitates nutrients and weight maintenance, experts say. (iStock)
In those over 80, restricting animal proteins may be less likely to promote longevity, according to Palinski-Wade, who was not involved in the study.
Eliminating all animal protein — particularly in a population that may already experience diminished hunger cues — can make it more difficult to meet adequate protein needs, potentially increasing the risk of nutrient deficiencies, the nutritionist said.
ALZHEIMER’S SYMPTOMS COULD BE PREDICTED YEARS IN ADVANCE THROUGH ONE SIMPLE TEST
In addition to a higher tendency to be underweight, older populations also face a greater risk of bone fractures due to lower calcium and protein intake.
Potential limitations
The lower rate of vegetarians reaching 100 was only observed in participants identified as underweight, the researchers noted. No such association was found in people who maintained a healthy weight.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Because being underweight is already linked to greater frailty and mortality risk, the researchers noted that body weight may partly explain the findings, making it difficult to determine whether diet itself played a direct role.
Those incorporating animal-sourced products other than meat were just as likely to live to 100. (iStock)
Additionally, the shortened lifespans were not found in people who continued to eat non-meat animal products, such as fish, dairy and eggs.
Older adults with these more flexible diets were just as likely to live to 100 as those eating meat, as these foods may provide the nutrients necessary for maintaining muscle and bone health, the researchers noted.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“This is an observational study, so it can only show associations, and does not prove that avoiding meat directly reduces the odds of reaching 100,” Palinski-Wade added.
CLICK HERE FOR MORE HEALTH STORIES
The researchers suggested that including small amounts of animal-sourced foods could help older seniors maintain essential nutrients and avoid the muscle loss often seen in those who stick strictly to plants.
Eliminating all animal protein — particularly in a population that may already experience diminished hunger cues — can make it more difficult to meet adequate protein needs, potentially increasing the risk of nutrient deficiencies. (iStock)
Palinski-Wade offered some guidance for those looking to optimize nutrition later in life.
“For adults in their 80s and beyond, especially anyone losing weight or muscle, the priority should be maintaining a healthy weight and meeting protein and micronutrient needs — even if that means adding or increasing fish, eggs, dairy or well‑planned, fortified plant proteins and supplements.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Strict vegan or very low‑protein patterns at that age should be carefully monitored by a dietitian or clinician, with attention to B12, vitamin D, calcium and total protein, according to Palinski-Wade.
“Younger and healthier adults can still confidently use plant‑forward or vegetarian patterns to lower long‑term chronic disease risk,” she added.
-
World6 days agoExclusive: DeepSeek withholds latest AI model from US chipmakers including Nvidia, sources say
-
Massachusetts7 days agoMother and daughter injured in Taunton house explosion
-
Denver, CO7 days ago10 acres charred, 5 injured in Thornton grass fire, evacuation orders lifted
-
Louisiana1 week agoWildfire near Gum Swamp Road in Livingston Parish now under control; more than 200 acres burned
-
Oregon5 days ago2026 OSAA Oregon Wrestling State Championship Results And Brackets – FloWrestling
-
Florida3 days agoFlorida man rescued after being stuck in shoulder-deep mud for days
-
Maryland3 days agoAM showers Sunday in Maryland
-
Culture1 week agoTry This Quiz on Thrilling Books That Became Popular Movies